Systemic administration of 5-HT2C receptor agonists attenuates muscular hyperalgesia in reserpine-induced myalgia model

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors

María Pompeiano, José Palacios, Guadalupe Mengod · Molecular Brain Research · 1994 · 873 citations

Genetics, 5-Ht2c Receptors, Neuropharmacology +2

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

Meredith C. Fidler, Matilde Sanchez, Brian Raether et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 561 citations

Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis

I. Jon Russell, Martin A. Javors, Fred Nyberg · Arthritis & Rheumatism · 1992 · 543 citations

Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study

Patrick M. O’Neil, Steven R. Smith, Neil J. Weissman et al. · Obesity · 2012 · 531 citations

Cardiometabolic Risk, Pharmacotherapy, Obesity +17

Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization

William Thomsen, Andrew J. Grottick, Frederique Menzaghi et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 401 citations